Cargando…
Antimicrobial Peptides: An Emerging Category of Therapeutic Agents
Antimicrobial peptides (AMPs), also known as host defense peptides, are short and generally positively charged peptides found in a wide variety of life forms from microorganisms to humans. Most AMPs have the ability to kill microbial pathogens directly, whereas others act indirectly by modulating th...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5186781/ https://www.ncbi.nlm.nih.gov/pubmed/28083516 http://dx.doi.org/10.3389/fcimb.2016.00194 |
_version_ | 1782486706371428352 |
---|---|
author | Mahlapuu, Margit Håkansson, Joakim Ringstad, Lovisa Björn, Camilla |
author_facet | Mahlapuu, Margit Håkansson, Joakim Ringstad, Lovisa Björn, Camilla |
author_sort | Mahlapuu, Margit |
collection | PubMed |
description | Antimicrobial peptides (AMPs), also known as host defense peptides, are short and generally positively charged peptides found in a wide variety of life forms from microorganisms to humans. Most AMPs have the ability to kill microbial pathogens directly, whereas others act indirectly by modulating the host defense systems. Against a background of rapidly increasing resistance development to conventional antibiotics all over the world, efforts to bring AMPs into clinical use are accelerating. Several AMPs are currently being evaluated in clinical trials as novel anti-infectives, but also as new pharmacological agents to modulate the immune response, promote wound healing, and prevent post-surgical adhesions. In this review, we provide an overview of the biological role, classification, and mode of action of AMPs, discuss the opportunities and challenges to develop these peptides for clinical applications, and review the innovative formulation strategies for application of AMPs. |
format | Online Article Text |
id | pubmed-5186781 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-51867812017-01-12 Antimicrobial Peptides: An Emerging Category of Therapeutic Agents Mahlapuu, Margit Håkansson, Joakim Ringstad, Lovisa Björn, Camilla Front Cell Infect Microbiol Microbiology Antimicrobial peptides (AMPs), also known as host defense peptides, are short and generally positively charged peptides found in a wide variety of life forms from microorganisms to humans. Most AMPs have the ability to kill microbial pathogens directly, whereas others act indirectly by modulating the host defense systems. Against a background of rapidly increasing resistance development to conventional antibiotics all over the world, efforts to bring AMPs into clinical use are accelerating. Several AMPs are currently being evaluated in clinical trials as novel anti-infectives, but also as new pharmacological agents to modulate the immune response, promote wound healing, and prevent post-surgical adhesions. In this review, we provide an overview of the biological role, classification, and mode of action of AMPs, discuss the opportunities and challenges to develop these peptides for clinical applications, and review the innovative formulation strategies for application of AMPs. Frontiers Media S.A. 2016-12-27 /pmc/articles/PMC5186781/ /pubmed/28083516 http://dx.doi.org/10.3389/fcimb.2016.00194 Text en Copyright © 2016 Mahlapuu, Håkansson, Ringstad and Björn. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Mahlapuu, Margit Håkansson, Joakim Ringstad, Lovisa Björn, Camilla Antimicrobial Peptides: An Emerging Category of Therapeutic Agents |
title | Antimicrobial Peptides: An Emerging Category of Therapeutic Agents |
title_full | Antimicrobial Peptides: An Emerging Category of Therapeutic Agents |
title_fullStr | Antimicrobial Peptides: An Emerging Category of Therapeutic Agents |
title_full_unstemmed | Antimicrobial Peptides: An Emerging Category of Therapeutic Agents |
title_short | Antimicrobial Peptides: An Emerging Category of Therapeutic Agents |
title_sort | antimicrobial peptides: an emerging category of therapeutic agents |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5186781/ https://www.ncbi.nlm.nih.gov/pubmed/28083516 http://dx.doi.org/10.3389/fcimb.2016.00194 |
work_keys_str_mv | AT mahlapuumargit antimicrobialpeptidesanemergingcategoryoftherapeuticagents AT hakanssonjoakim antimicrobialpeptidesanemergingcategoryoftherapeuticagents AT ringstadlovisa antimicrobialpeptidesanemergingcategoryoftherapeuticagents AT bjorncamilla antimicrobialpeptidesanemergingcategoryoftherapeuticagents |